CRVO
CervoMed Inc.
3.00$
+3.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 130.2% | – | 117.4% | 114.6% | 119.9% | 244.6% | 264.2% | 327.8% | 252.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -30.2% | – | -17.4% | -14.7% | -19.9% | 100.0% | -164.2% | -227.8% | -152.3% | -190.6% | 100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 130.2% | – | 117.4% | 114.6% | 119.9% | 114.7% | 264.2% | 327.8% | 252.4% | 290.6% | 1,872.6% | 66,814.2% | – | – | 6,437.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 71.1% | – | 157.9% | 84.9% | 90.7% | 76.4% | 114.0% | 107.1% | 124.3% | 185.8% | 721.2% | 28,765.0% | – | – | 3,069.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 101.3% | – | 175.3% | 99.6% | 110.6% | 91.1% | 278.2% | 334.9% | 276.6% | 376.4% | 2,593.8% | 95,479.2% | – | – | 9,504.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -101.3% | – | -175.3% | -99.6% | -110.6% | -91.1% | -278.2% | -334.9% | -276.6% | -376.4% | -2,493.8% | -95,479.2% | – | – | -9,407.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -38.0% | – | 140.9% | -94.8% | -107.1% | -70.4% | -245.0% | -310.2% | -255.3% | -356.1% | -2,395.3% | -92,680.4% | – | – | -9,160.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -101.3% | – | -175.3% | 32.1% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -38.0% | – | 140.9% | -94.8% | -107.1% | -70.4% | -245.0% | -310.2% | -255.3% | -356.1% | -2,395.3% | -92,680.4% | – | – | -9,160.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -38.0% | – | 140.9% | 126.9% | -107.1% | -70.4% | -245.0% | -310.2% | -255.3% | -356.1% | -2,395.3% | -92,680.4% | – | – | -9,160.9% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.